Prognostic significance of bleeding definitions in clinical investigations of oral anticoagulants
口服抗凝剂临床研究中出血定义的预后意义
基本信息
- 批准号:467079
- 负责人:
- 金额:$ 1.27万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Studentship Programs
- 财政年份:2021
- 资助国家:加拿大
- 起止时间:2021-12-01 至 2022-12-01
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Anticoagulants, or blood-thinners, are used to treat a variety of conditions such as a clot in the limbs or lungs. They are also used to prevent clot formation in high-risk individuals, such as in those with certain heart rhythm conditions (known as atria
抗凝剂或血液稀释剂被用来治疗各种疾病,如四肢或肺部的血栓。它们也被用来防止高危个体的血栓形成,例如那些有特定心律状况(称为心房)的人
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Xu Yan其他文献
Radio Luminosity, Black Hole Mass and Eddington Ratio for Quasars from the Sloan Digital Sky Survey
斯隆数字巡天中类星体的射电光度、黑洞质量和爱丁顿比
- DOI:
10.1088/1009-9271/8/5/03 - 发表时间:
2008-03 - 期刊:
- 影响因子:0
- 作者:
Bian Wei-Hao;Xu Yan;Huang Kai;Chen Yan-Mei;Hu Chen - 通讯作者:
Hu Chen
Normal families and fixed-points of meromorphic functions
亚纯函数的正规族和不动点
- DOI:
10.1007/s00605-015-0847-z - 发表时间:
2015-11 - 期刊:
- 影响因子:0.9
- 作者:
Xu Yan - 通讯作者:
Xu Yan
Xu Yan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Xu Yan', 18)}}的其他基金
Long-Term Risk of All-Cause Mortality Following Anticoagulant Cessation for Unprovoked Venous Thromboembolism: A Systematic Review and Meta-Analysis
无端静脉血栓栓塞停止抗凝治疗后全因死亡的长期风险:系统评价和荟萃分析
- 批准号:
481024 - 财政年份:2023
- 资助金额:
$ 1.27万 - 项目类别:
Barriers and Facilitators to Venous Thromboembolism Research Participation in Underrepresented Ethnoracial Groups
代表性不足的民族群体参与静脉血栓栓塞研究的障碍和促进因素
- 批准号:
460951 - 财政年份:2022
- 资助金额:
$ 1.27万 - 项目类别:
Miscellaneous Programs
Evaluation of Definitions for Oral Anticoagulant-Associated Major Bleeding: A Population-Based Cohort Study
口服抗凝剂相关大出血定义的评估:基于人群的队列研究
- 批准号:
391654 - 财政年份:2018
- 资助金额:
$ 1.27万 - 项目类别:
Anticoagulant Re-Initiation following Intracranial Hemorrhage in Non-Valvular Atrial Fibrillation: Practices and Perceptions of Thrombosis Experts, Neurologists and Neurosurgeons
非瓣膜性心房颤动颅内出血后重新启动抗凝治疗:血栓专家、神经科医生和神经外科医生的实践和看法
- 批准号:
364647 - 财政年份:2017
- 资助金额:
$ 1.27万 - 项目类别:
Impact of joint replacement surgery trends on lumbar fusion for degenerative conditions.
关节置换手术趋势对退行性疾病腰椎融合的影响。
- 批准号:
348302 - 财政年份:2016
- 资助金额:
$ 1.27万 - 项目类别:
Studentship Programs
Reversal strategies and outcomes of major bleeding associated with direct oral anticoagulants and warfarin in routine practice: interim results from a multi-centre cohort
常规实践中与直接口服抗凝剂和华法林相关的大出血的逆转策略和结果:多中心队列的中期结果
- 批准号:
352247 - 财政年份:2016
- 资助金额:
$ 1.27万 - 项目类别:
Determinants of health-related quality of life among patients with von Willebrand disease.
冯·维勒布兰德病患者健康相关生活质量的决定因素。
- 批准号:
324083 - 财政年份:2015
- 资助金额:
$ 1.27万 - 项目类别:
Impact of Survey and Demographics on Performance Measurement in Public Health: Comparison of National and International Metrics.
调查和人口统计对公共卫生绩效衡量的影响:国家和国际指标的比较。
- 批准号:
340999 - 财政年份:2015
- 资助金额:
$ 1.27万 - 项目类别:
Miscellaneous Programs
Prescribing Pattern of Novel Oral Anticoagulants for Atrial Fibrillation in Ontario, Canada.
加拿大安大略省新型口服抗凝剂治疗心房颤动的处方模式。
- 批准号:
278167 - 财政年份:2013
- 资助金额:
$ 1.27万 - 项目类别:
HLA polymorphism in cytoplasmic tail as predictive factor for rheumatoid arthritis
细胞质尾部HLA多态性作为类风湿性关节炎的预测因素
- 批准号:
183621 - 财政年份:2009
- 资助金额:
$ 1.27万 - 项目类别:
Studentship Programs
相似海外基金
2/2 REACT-AF: Rhythm Evaluation for AntiCoagulaTion with Continuous Monitoring of Atrial Fibrillation
2/2 REACT-AF:通过连续监测心房颤动进行抗凝心律评估
- 批准号:
10509053 - 财政年份:2022
- 资助金额:
$ 1.27万 - 项目类别:
Effectiveness and Safety of Transcatheter Left Atrial Appendage Occlusion vs. Anticoagulation in Older Adults with Atrial Fibrillation and Alzheimer's Disease and Related dementias
经导管左心耳封堵术与抗凝治疗对患有心房颤动、阿尔茨海默病及相关痴呆症的老年人的有效性和安全性
- 批准号:
10672458 - 财政年份:2022
- 资助金额:
$ 1.27万 - 项目类别:
The Rhythm Evaluation for Anticoagulation with Continuous Monitoring of Atrial Fibrillation Trial (REACT-AF)
心房颤动连续监测试验的抗凝节律评估 (REACT-AF)
- 批准号:
10509310 - 财政年份:2022
- 资助金额:
$ 1.27万 - 项目类别:
The Rhythm Evaluation for Anticoagulation with Continuous Monitoring of Atrial Fibrillation Trial (REACT-AF)
心房颤动连续监测试验的抗凝节律评估 (REACT-AF)
- 批准号:
10725186 - 财政年份:2022
- 资助金额:
$ 1.27万 - 项目类别:
Effectiveness and Safety of Transcatheter Left Atrial Appendage Occlusion vs. Anticoagulation in Older Adults with Atrial Fibrillation and Alzheimer's Disease and Related dementias
经导管左心耳封堵术与抗凝治疗对患有心房颤动、阿尔茨海默病及相关痴呆症的老年人的有效性和安全性
- 批准号:
10443345 - 财政年份:2022
- 资助金额:
$ 1.27万 - 项目类别:
Anticoagulation Therapy Timing in Atrial Fibrillation after Chronic Subdural Hematoma External Drainage(the ATTACHED RCT)
慢性硬膜下血肿外引流术后心房颤动的抗凝治疗时机(附随机对照试验)
- 批准号:
443046 - 财政年份:2021
- 资助金额:
$ 1.27万 - 项目类别:
Operating Grants
The "Atrial FIBrillation in Pregnancy: assessing seveRe matErnal morbidity and anticoagulation strateGies" (AFIB-PREG) Study
“妊娠期心房颤动:评估严重孕产妇发病率和抗凝策略”(AFIB-PREG) 研究
- 批准号:
444740 - 财政年份:2021
- 资助金额:
$ 1.27万 - 项目类别:
Operating Grants
Shared Decision-Making to Reduce Racial Disparities in Oral Anticoagulation Use in Patients with Non-Valvular Atrial Fibrillation
共同决策以减少非瓣膜性心房颤动患者口服抗凝药使用中的种族差异
- 批准号:
10471407 - 财政年份:2021
- 资助金额:
$ 1.27万 - 项目类别:
Anticoagulation for stroke prevention in patients with recent episodes of perioperative atrial fibrillation after noncardiac surgery - The ASPIRE-AF study
非心脏手术后近期发生围手术期心房颤动的患者抗凝预防中风 - ASPIRE-AF 研究
- 批准号:
444394 - 财政年份:2021
- 资助金额:
$ 1.27万 - 项目类别:
Operating Grants
Shared Decision-Making to Reduce Racial Disparities in Oral Anticoagulation Use in Patients with Non-Valvular Atrial Fibrillation
共同决策以减少非瓣膜性心房颤动患者口服抗凝药使用中的种族差异
- 批准号:
10282856 - 财政年份:2021
- 资助金额:
$ 1.27万 - 项目类别: